It is known that Nav1.5 expression in breast cancer cells is closely associated with the protein level of CD44, which correlates with poor outcomes of breast cancer (McFarlane et al., 2015; Nelson et al., 2015b). The gene discussed is CD44; the disease is breast carcinoma.